A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination
Coronavirus disease 2019 (COVID-19) is the most dramatic pandemic of the new millennium; to counteract it, specific vaccines have been launched in record time under emergency use authorization or conditional marketing authorization by virtue of a favorable risk/benefit balance. Among the various tec...
Main Authors: | Luca Roncati, Antonio Manenti, Lorenzo Corsi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/11/4/435 |
Similar Items
-
Editorial: Post COVID-19: the nucleoside-modified messenger RNA (modRNA) platform
by: Luca Roncati, et al.
Published: (2024-01-01) -
Cubital Tunnel Syndrome Temporally after COVID-19 Vaccination
by: Luca Roncati, et al.
Published: (2022-04-01) -
Pericardite aguda após vacina contra COVID-19
by: Nina Lopes, et al.
Published: (2022-12-01) -
Erythematous reaction of the BCG site to Pfizer‐BioNTech COVID‐19 vaccine
by: Yuta Ito, et al.
Published: (2023-10-01) -
Qualitative Assessment of Early Adverse Effects of Pfizer–BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews
by: Sami Abu-Halaweh, et al.
Published: (2021-08-01)